中山市力恩普制药

Zhongshan Leap Pharmaceutical is a specialized pharmaceutical company based in Zhongshan, China, and a key subsidiary of the Livzon Pharmaceutical Group. The company focuses on the development and commercialization of high-barrier complex formulations, with a particular emphasis on long-acting injectable microsphere technology. Its product portfolio and pipeline target significant therapeutic areas including psychiatry, endocrinology, and oncology. By leveraging advanced drug delivery platforms, Leap Pharmaceutical aims to provide sustained-release treatments that improve patient adherence and clinical efficacy. The company operates modern manufacturing facilities that comply with international GMP standards to support both domestic and global markets.